Groups Sue FDA Over Approval of Genetically Engineered Salmon
A broad coalition of organizations sued the U.S. Food and Drug Administration (FDA) today for approving the first-ever genetically engineered (GE) food animal, an Atlantic salmon engineered to grow quickly. The man-made salmon was created by AquaBounty Technologies, Inc. with DNA from three fish: Atlantic salmon, Pacific king salmon and Arctic ocean eelpout. This marks the first time any government in the world has approved a GE animal for commercial sale and consumption.
“FDA's decision is as unlawful as it is irresponsible," George Kimbrell, senior attorney for Center for Food Safety and co-counsel for the plaintiffs, said. “This case is about protecting our fisheries and ocean ecosystems from the foreseeable harms of the first-ever GE fish, harms FDA refused to even consider, let alone prevent. But it's also about the future of our food: FDA should not, and cannot, responsibly regulate this GE animal, nor any future GE animals, by treating them as drugs under a 1938 law."
In approving the GE salmon, FDA determined it would not require labeling of the GE fish to let consumers know what they are buying, which led Congress to call for labeling in the 2016 omnibus spending bill. FDA's approval also ignored comments from nearly 2 million people opposed to the approval because the agency failed to analyze and prevent the risks to wild salmon and the environment, as well as fishing communities, including the risk that GE salmon could escape and threaten endangered wild salmon stocks.
“It's clear that the market has rejected GE salmon despite FDA's reckless approval," Dana Perls, food and technology campaigner for Friends of the Earth, said. “Major retailers including Costco, Safeway and Kroger won't sell it and polls show the vast majority of people don't want to eat it. Yet under this approval it won't be labeled, violating our fundamental right to know what we are feeding our families."
AquaBounty's GE salmon will undertake a 5,000-mile journey to reach U.S. supermarkets. The company plans to produce the GE salmon eggs on Prince Edward Island, Canada. The GE salmon will then be grown to market-size in a facility in Panama, processed into fillets and shipped to the U.S. for sale. That complicated scheme is only for the initial approval, however. AquaBounty has publicly announced plans to ultimately grow its GE fish in the U.S. rather than Panama and sell it around the world. Despite this, FDA's approval only considered the current plans for the far-flung facilities in Canada and Panama, leaving the risk of escape and contamination of U.S. salmon runs unstudied.
The lawsuit challenges FDA's claim that it has authority to approve and regulate GE animals as “animal drugs" under the 1938 Federal Food, Drug and Cosmetic Act. Those provisions were meant to ensure the safety of veterinary drugs administered to treat disease in livestock and were not intended to address entirely new GE animals that can pass along their altered genes to the next generation. The approval of the GE salmon opens the door to other genetically engineered fish and shellfish, as well as chickens, cows, sheep, goats, rabbits and pigs that are reportedly in development.
The lawsuit also highlights FDA's failure to protect the environment and consult wildlife agencies in its review process, as required by federal law. U.S. Atlantic salmon and many populations of Pacific salmon, are protected by the Endangered Species Act and in danger of extinction. Salmon is a keystone species and unique runs have been treasured by residents for thousands of years. Diverse salmon runs today sustain thousands of American fishing families and are highly valued in domestic markets as a healthy, domestic, “green" food.
“Atlantic salmon populations including our endangered Gulf of Maine fish are hanging on by a thread—they can't afford additional threats posed by GE salmon," said Ed Friedman from Friends of Merrymeeting Bay, one of the parties who successfully petitioned to classify most Maine Atlantic salmon as endangered. “The law requires agencies like FDA, who aren't fisheries biologists, to get review and approval from scientists with that expertise. FDA's refusal to do this before allowing commercialization of GE salmon is not only irresponsible, it violates the law."
When GE salmon escape or are accidentally released into the environment, the new species could threaten wild populations by mating with endangered salmon species, outcompeting them for scarce resources and habitat and/or introducing new diseases. Studies have shown that there is a high risk for GE organisms to escape into the natural environment and that GE salmon can crossbreed with native fish. Transgenic contamination has become common in the GE plant context, where contamination episodes have cost U.S. farmers billions of dollars over the past decade. In wild organisms like fish, it could be even more damaging.
“Once they escape, you can't put these transgenic fish back in the bag. They're manufactured to outgrow wild salmon, and if they cross-breed, it could have irreversible impacts on the natural world," Dune Lankard, a salmon fisherman and the Center for Biological Diversity's Alaska representative, said. “This kind of dangerous tinkering could easily morph into a disaster for wild salmon that will be impossible to undo."
The world's preeminent experts on GE fish and risk assessment, as well as biologists at U.S. wildlife agencies charged with protecting fish and wildlife heavily criticized the FDA decision for failing to evaluate these impacts. FDA ignored their concerns in the final approval.
“The FDA has failed to adequately examine the risks associated with transgenic salmon," Wenonah Hauter, executive director of Food & Water Watch, said. “The long term effects of people eating genetically modified foods have never been adequately addressed—and this GE salmon is no exception. This fish is unnecessary, so why take the risk?"
The plaintiff coalition, jointly represented by legal counsel from Center for Food Safety and Earthjustice, includes Pacific Coast Federation of Fishermen's Associations, Institute for Fisheries Resources, Golden Gate Salmon Association, Kennebec Reborn, Friends of Merrymeeting Bay, Ecology Action Centre, Food & Water Watch, Center for Biological Diversity, Friends of the Earth, Cascadia Wildlands and Center for Food Safety.
YOU MIGHT ALSO LIKE
By Gudrun Heise
Just as scientists are scoring successes in coronavirus research, new problems are on their way. Fall is with us and winter is around the corner, so the season for colds and flu has begun — joining COVID-19.
Influenza Vaccination<p>A flu vaccination may thus be able to narrow down the diagnostic options when flu-like symptoms occur, but whether such a vaccination also has an influence on the behavior of the dangerous new virus is — like so much else — not clear. "It is conceivable that there is an indirect effect. But it is, I believe, a matter of speculation whether it has an immunological effect in the narrower sense," says Krause.</p><p>Every winter, doctors' waiting rooms are full of people who are coughing and sniffing but who mostly turn out to have only a severe respiratory infection. According to current knowledge, the virus that causes COVID-19, SARS-CoV-2, is also likely to be subject to seasonal fluctuations. </p><p>In winter, cold viruses, at least, flourish because cold and dry air offers ideal conditions for their spread. In addition, it becomes more difficult to air rooms regularly and intensively — an important further measure to counteract the coronavirus and contain to some extent the danger posed by aerosols.</p><p>According to the <a href="https://www.rki.de/DE/Home/homepage_node.html" target="_blank">Robert Koch Institute, Germany's public health agency</a>, between 5% and 20% of people in Germany become infected with flu viruses every year. These viruses are also dangerous and can be fatal. The flu vaccination must be adapted to the influenza viruses every year, because they mutate. But at least there is a vaccination.</p><p>Most experts agree that there is unlikely to be a vaccine against the coronavirus by the time the next wave of influenza comes around. And even if a vaccine were to be approved, many unknowns remain.</p>
COVID-19 and Flu Simultaneously<p>For example, there is a lack of practical experience in dealing simultaneously with SARS-CoV-2 and influenza. It is possible to speculate that having influenza could facilitate the entry of the coronavirus into the human body. "The general weakening of the immune system during an influenza infection could increase the susceptibility of a patient to a SARS-CoV-2 infection," Krause says.</p><p>However, it is uncertain how dangerous this double infection could ultimately be and what can be done about it. Krause is of the opinion that we must arm ourselves against all three diseases — colds, flu and COVID-19. If we have a cold, bed rest, hot tea and cough medicine usually help. We can get vaccinated against flu. But how do we deal with COVID-19?</p><p><span></span>Probably people can only hope that if they get the illness, they will have a mild form with as few after-effects as possible. Here, it will certainly help to stick to suggested rules on hygiene to reduce or prevent our exposure to the virus. In an interview with DW, Bonn-based virology professor Hendrik Streeck made it clear that COVID-19 usually takes a more severe course when there is a high viral load at infection.</p>
Hygiene, Hygiene, Hygiene<p>The same hygiene measures with which we are trying to get at least some kind of grip on COVID-19 also apply to influenza. The less we come into contact with viruses, the greater the chance that we will be spared an infection or that it will be mild.</p><p>These measures include general hygiene precautions such as frequent hand washing and the wearing of protective face masks. "The various hygienic measures against COVID-19 will also reduce the spread of influenza," says Krause. "Possibly, further connections of a more immunological nature will be discovered."</p><p>Let us hope that is the case, because the flu season hasn't even started.</p>
- Fauci Warns Bad Second Wave of Coronavirus Could Hit U.S. ... ›
- U.S. Coronavirus Death Toll Tops 170,000 Ahead of Flu Season ... ›
- COVID-19 Makes Getting a Flu Shot More Important Than Ever ... ›
EcoWatch Daily Newsletter
Rising temperatures in the air and the water surrounding Greenland are melting its massive ice sheet at a faster rate than anytime in the last 12 millennia, according to a new study published Wednesday in the journal Nature.
- Greenland and Antarctica Already Melting at 'Worst-Case-Scenario ... ›
- Warmer Current Is Carving Away Greenland Ice Sheet From Below ... ›
- Greenland's Ice Sheet Is Melting at Rate That Surpasses Scientists ... ›
- Greenland's Ice Sheet Has Reached 'Point of No Return' - EcoWatch ›
- Record Shrinking of Greenland's Ice Sheet Raises Sea Levels ... ›
- Greenland Ice Sheet Melt Creates Huge Waterfalls, Increasing ... ›
A grim new assessment of the world's flora and fungi has found that two-fifths of its species are at risk of extinction as humans encroach on the natural world, as The Guardian reported. That puts the number of species at risk near 140,000.
- Climate Crisis Could Cause a Third of Plant and Animal Species to ... ›
- World Leaders Urged to 'Act Now' to Save Biodiversity - EcoWatch ›
- Bumblebees Face Extinction From the Climate Crisis - EcoWatch ›
- Plant Extinction Is Happening 500x Faster Than Before the Industrial ... ›
As human activity transforms the atmosphere, flowers are changing their colors.
- The Best Plants to Attract Pollinators, by Region - EcoWatch ›
- Corals Turn Bright Neon in Last-Ditch Effort to Survive - EcoWatch ›
- Hummingbirds Live in a More Colorful World, Study Confirms ... ›
By Sharon Zhang
Back in March, when the pandemic had just planted its roots in the U.S., President Donald Trump directed the Environmental Protection Agency (EPA) to do something devastating: The agency was to indefinitely and cruelly suspend environmental rule enforcement. The EPA complied, and for just under half a year, it provided over 3,000 waivers that granted facilities clemency from state-level environmental rule compliance.